Aethlon Medical Inc (AEMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Aethlon Medical Inc stock (AEMD) is currently trading at $2.16. Aethlon Medical Inc PS ratio (Price-to-Sales) is 2.37. Analyst consensus price target for AEMD is $4.75. WallStSmart rates AEMD as Sell.
- AEMD PE ratio analysis and historical PE chart
- AEMD PS ratio (Price-to-Sales) history and trend
- AEMD intrinsic value — DCF, Graham Number, EPV models
- AEMD stock price prediction 2025 2026 2027 2028 2029 2030
- AEMD fair value vs current price
- AEMD insider transactions and insider buying
- Is AEMD undervalued or overvalued?
- Aethlon Medical Inc financial analysis — revenue, earnings, cash flow
- AEMD Piotroski F-Score and Altman Z-Score
- AEMD analyst price target and Smart Rating
Aethlon Medical Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Aethlon Medical Inc (AEMD) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, revenue growth. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Aethlon Medical Inc (AEMD) Key Strengths (2)
Trading below book value, meaning the market prices it less than net assets
Revenue surging 4278.00% year-over-year
Supporting Valuation Data
Aethlon Medical Inc (AEMD) Areas to Watch (4)
Company is destroying shareholder value
Very low institutional interest at 6.43%
Micro-cap company with very limited liquidity and high volatility
Revenue is fairly priced at 2.37x sales
Supporting Valuation Data
Aethlon Medical Inc (AEMD) Detailed Analysis Report
Overall Assessment
This company scores 34/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 2 register as strengths (avg 10.0/10) while 4 fall into concern territory (avg 2.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Revenue Growth. Valuation metrics including Price/Book (0.42) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 4278.00%.
The Bear Case
The primary concerns are Return on Equity, Institutional Own., Market Cap. Some valuation metrics including Price/Sales (2.37) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -208.60%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -208.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 4278.00% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Institutional Own. are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AEMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AEMD's Price-to-Sales ratio of 2.37x trades at a deep discount to its historical average of 5.56x (40th percentile). The current valuation is 91% below its historical high of 25.71x set in Oct 2019, and 3855% above its historical low of 0.06x in Nov 2012.
WallStSmart Analysis Synopsis
Data-driven financial summary for Aethlon Medical Inc (AEMD) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Aethlon Medical Inc is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 574,240 with 4278% growth year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Revenue growing at 4278% YoY, reaching 574,240. This pace significantly outperforms most MEDICAL DEVICES peers.
Spending 93% of revenue (532,782) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Aethlon Medical Inc maintain 4278%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 1.65, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Aethlon Medical Inc.
Bottom Line
Aethlon Medical Inc is a high-conviction growth story with revenue accelerating at 4278% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 0.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Aethlon Medical Inc(AEMD)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California.